Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lactoferrin as potential preventative and adjunct treatment for COVID-19
Raymond Chang, Tzi Bun Ng, Wei‐Zen Sun
International Journal of Antimicrobial Agents (2020) Vol. 56, Iss. 3, pp. 106118-106118
Open Access | Times Cited: 149

Showing 1-25 of 149 citing articles:

The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators
Hosam M. Habib, Sahar Ibrahim, Aamnah Zaim, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 136, pp. 111228-111228
Open Access | Times Cited: 227
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial
Francesco Di Pierro, Somia Iqtadar, Amjad Khan, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 2807-2816
Open Access | Times Cited: 150
Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation
Elena Campione, Terenzio Cosio, Luigi Rosa, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4903-4903
Open Access | Times Cited: 102
COVID-19, cytokines, inflammation, and spices: How are they related?
Ajaikumar B. Kunnumakkara, Varsha Rana, Parama Dey, et al.
Life Sciences (2021) Vol. 284, pp. 119201-119201
Open Access | Times Cited: 95
Diverse Mechanisms of Antimicrobial Activities of Lactoferrins, Lactoferricins, and Other Lactoferrin-Derived Peptides
Špela Gruden, Nataša Poklar Ulrih
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11264-11264
Open Access | Times Cited: 95
Protective Effects of Lactoferrin against SARS-CoV-2 Infection In Vitro
Claudio Salaris, Melania Scarpa, Marina Elli, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 328-328
Open Access | Times Cited: 92
Lactoferrin and Its Derived Peptides: An Alternative for Combating Virulence Mechanisms Developed by Pathogens
Daniela Zarzosa-Moreno, Christian Avalos-Gómez, Luisa Sofía Ramírez-Texcalco, et al.
Molecules (2020) Vol. 25, Iss. 24, pp. 5763-5763
Open Access | Times Cited: 84
Promoting and Protecting Human Milk and Breastfeeding in a COVID-19 World
Diane L. Spatz, Riccardo Davanzo, Janis A. Müller, et al.
Frontiers in Pediatrics (2021) Vol. 8
Open Access | Times Cited: 63
A Review on Lactoferrin and Central Nervous System Diseases
Yu-Qi Li, Chuang Guo
Cells (2021) Vol. 10, Iss. 7, pp. 1810-1810
Open Access | Times Cited: 63
Whey proteins and peptides in health-promoting functions – A review
Changhui Zhao, Nan Chen, Tolulope Joshua Ashaolu
International Dairy Journal (2021) Vol. 126, pp. 105269-105269
Closed Access | Times Cited: 63
Bioactives in bovine milk: chemistry, technology, and applications
Tiantian Lin, G. H. Meletharayil, Rohit Kapoor, et al.
Nutrition Reviews (2021) Vol. 79, Iss. Supplement_2, pp. 48-69
Open Access | Times Cited: 61
Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2
Valeria De Pasquale, Miriam Shasa Quiccione, Simona Tafuri, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6574-6574
Open Access | Times Cited: 60
SARS-CoV-2 Antiviral Therapy
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 4
Open Access | Times Cited: 57
Molecular Mechanisms Behind Anti SARS-CoV-2 Action of Lactoferrin
Mattia Miotto, Lorenzo Di Rienzo, Leonardo Bò, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 56
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 16, pp. 1653-1708
Open Access | Times Cited: 52
Iron and iron-related proteins in COVID-19
Erin Suriawinata, Kosha J. Mehta
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 4, pp. 969-991
Open Access | Times Cited: 47
Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern
Jesse W. Wotring, Reid Fursmidt, Loren S. Ward, et al.
Journal of Dairy Science (2022) Vol. 105, Iss. 4, pp. 2791-2802
Open Access | Times Cited: 45
Lactoferrin for COVID-19 prevention, treatment, and recovery
Ecem Bolat, Furkan Eker, Merve Kaplan, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 39
Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID
A. Satyanarayan Naidu, Chin‐Kun Wang, Pingfan Rao, et al.
npj Science of Food (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 8
The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm
Michał Zimecki, Jeffrey K. Actor, Marian L. Kruzel
International Immunopharmacology (2021) Vol. 95, pp. 107571-107571
Open Access | Times Cited: 53
Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19
Fahadul Islam, Shabana Bibi, Atkia Farzana Khan Meem, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12638-12638
Open Access | Times Cited: 50
Could nutritional supplements act as therapeutic adjuvants in COVID-19?
Giorgio Costagliola, Erika Spada, Pasquale Comberiati, et al.
˜The œItalian Journal of Pediatrics/Italian journal of pediatrics (2021) Vol. 47, Iss. 1
Open Access | Times Cited: 46
Races of small molecule clinical trials for the treatment of COVID‐19: An up‐to‐date comprehensive review
Suwen Hu, Songwei Jiang, Qi Xiang, et al.
Drug Development Research (2021) Vol. 83, Iss. 1, pp. 16-54
Open Access | Times Cited: 46
The Antiviral Properties of Human Milk: A Multitude of Defence Tools from Mother Nature
Daniela Morniroli, Alessandra Consales, Beatrice Letizia Crippa, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 694-694
Open Access | Times Cited: 44
Ambulatory COVID-19 Patients Treated with Lactoferrin as a Supplementary Antiviral Agent: A Preliminary Study
Luigi Rosa, Giovanni Tripepi, Enrico Naldi, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 18, pp. 4276-4276
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top